Fleischer Kristina, Schmidt Burkhard, Kastenmüller Wolfgang, Busch Dirk H, Drexler Ingo, Sutter Gerd, Heike Michael, Peschel Christian, Bernhard Helga
Department of Hematology/Oncology, Klinikum rechts der Isar, Technical University of Munich, Ismaningerstrasse 22, D-81675 Munich, Germany.
J Immunol. 2004 Jan 1;172(1):162-9. doi: 10.4049/jimmunol.172.1.162.
Immunization with heat shock proteins (hsp) isolated from cancer cells has been shown to induce a protective antitumor response. The mechanism of hsp-dependent cellular immunity has been attributed to a variety of immunological activities mediated by hsp. Hsp have been shown to bind antigenic peptides, trim the bound peptides by intrinsic enzymatic activity, improve endocytosis of the chaperoned peptides by APCs, and enhance the ability of APCs to stimulate peptide-specific T cells. We have investigated the potential capacity of hsp70 and gp96 to function as a mediator for Ag-specific CTL stimulation in an in vitro model for human melanoma. Repetitive stimulation of PBLs by autologous DCs loaded with melanoma-derived hsp did not increase the frequency of T cells directed against immunodominant peptides of melanoma-associated Ags Melan-A and tyrosinase. In contrast, repeated T cell stimulation with peptide-pulsed DCs enhanced the number of peptide-specific T cells, allowing HLA/peptide multimer-guided T cell cloning. We succeeded in demonstrating that the established HLA-A2-restricted CTL clones recognized HLA-A2(+) APCs exogenously loaded with the respective melanoma peptide as well as melanoma cells processing and presenting these peptides in the context of HLA-A2. We were not able to show that these melanoma-reactive CTL clones were stimulated by autologous dendritic cells pulsed with melanoma-derived hsp. These results are discussed with respect to various models for proving the role of hsp in T cell stimulation and to recent findings that part of the immunological antitumor activities reported for hsp are independent of the chaperoned peptides.
从癌细胞中分离出的热休克蛋白(hsp)免疫已被证明可诱导保护性抗肿瘤反应。hsp依赖性细胞免疫的机制归因于hsp介导的多种免疫活性。hsp已被证明可结合抗原肽,通过内在酶活性修剪结合的肽,改善抗原呈递细胞(APC)对伴侣肽的内吞作用,并增强APC刺激肽特异性T细胞的能力。我们在人黑色素瘤的体外模型中研究了hsp70和gp96作为Ag特异性CTL刺激介质的潜在能力。用负载黑色素瘤来源hsp的自体DC重复刺激外周血淋巴细胞(PBL)并没有增加针对黑色素瘤相关抗原Melan-A和酪氨酸酶的免疫显性肽的T细胞频率。相反,用肽脉冲DC重复刺激T细胞增加了肽特异性T细胞的数量,从而实现了HLA/肽多聚体引导的T细胞克隆。我们成功证明,已建立的HLA-A2限制性CTL克隆可识别外源负载相应黑色素瘤肽的HLA-A2(+) APC,以及在HLA-A2背景下加工和呈递这些肽的黑色素瘤细胞。我们未能证明这些黑色素瘤反应性CTL克隆受到用黑色素瘤来源hsp脉冲的自体树突状细胞的刺激。结合各种证明hsp在T细胞刺激中作用的模型以及最近关于hsp报道的部分免疫抗肿瘤活性独立于伴侣肽的发现,对这些结果进行了讨论。